InvestorsHub Logo

db7

Followers 221
Posts 39709
Boards Moderated 0
Alias Born 09/02/2003

db7

Member Level

Re: db7 post# 316

Thursday, 06/26/2014 10:36:02 AM

Thursday, June 26, 2014 10:36:02 AM

Post# of 514
excerpt: "HPPI is presently working towards an anticipated 2014 filing of an Investigational New Drug (IND) Application aimed at securing FDA approval to begin a corporate-sponsored clinical trial with HPPI's primary drug candidate, SUBA™-Itraconazole for the treatment of basal cell carcinoma (BCC), and to commence and conduct such trial. HPPI holds the exclusive U.S. rights to SUBA-Itraconazole from Mayne Pharma for the treatment of cancer. Mayne Pharma will also supply SUBA-Itraconazole for HPPI's currently contemplated and future clinical trials.
"

-------------------------------------------------------------------

All posts are strictly my opinion and are not buy or sell recommendations.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INTI News